Saeid Mirzai

Clinical & T32🫀fellow @WFCardiology | Alumnus @ClevelandClinic, @ACOMEDU, & @UF | #Sarcopenia #Obesity

[Rishi Rikhi, MD🌱MS @RishiRikhiMD]

In MESA and UK Biobank, we found that IL-6 remained independently associated with ASCVD after adjustments for LDL-C, Lp(a), and hsCRP.
@PCVDJournal @DrMichaelShapir

https://t.co/PA1bBzM7XH

[Roger Blumenthal @rblument1]

Comparative associations of LDL-C, Lp(a), hsCRP, & IL-6 with cardiovascular risk: Insights from United Kingdom (UK) biobank & MESA- led by Drs. James McParland, Rishi Rikhi & head Coach Michael Shapiro @ciccaronecenter https://t.co/TTSITSsIOl

[Saeid Mirzai @SaeidMirzaiDOMS]

Congratulations to Dr. Shapiro on this well-deserved award! I am grateful for your mentorship and the example you set. @DrMichaelShapir

[Roger Blumenthal @rblument1]

Congrats to @DrMichaelShapir on this great honor. Dr. Shapiro has done a marvelous job as President of ASPC and was a key member of the writing group of the practice-changing 2026 ACC/AHA/Multisociety Dyslipidemia Guideline. Congratulations, Michael on the Arthur Agatston award!

[Parag Chevli MD MS @paragchevli]

🚨 New in @JAHA_AHA

In ~91,000 UK Biobank participants free of CVD, higher circulating ketone bodies were linked to greater risk of ASCVD, HF, stroke, CV death, and mortality, but not MI.

Potential marker of cardiometabolic risk.

🔗https://t.co/0Pi5Zut1Vn

#KetoneBodies #UKBB

[Taha Hatab @Taha_Hatab1]

Excited to share our TTVR outcomes paper, now in press @crfshj

✅ Low in-hospital ☠️, high procedural success, improvement in QoL
🔹 EVOQUE: lower 30-day mortality vs other THVs, but higher PPM rate 🔌⚡️

Grateful for the mentorship of Dr @tavrkapadia!

https://t.co/T2ylQYVx0O

[Richard Kazibwe, MD, MS, FACP @Kazibwe_md]

Our recent study from SPRINT shows atherogenic dyslipidemia (low HDL + high TG) raises CVD risk, even with intensive BP control. Early detection in hypertension is key. https://t.co/CWDL851zDB #CardioTwitter #Hypertension

[Saeid Mirzai @SaeidMirzaiDOMS]

Grateful to Dr. Peters for his mentorship and guidance on our comprehensive review of exercise interventions in HFpEF, evaluating various training modalities and their impact on patient outcomes. https://t.co/xb5k6fiOrE

[Anthony Peters @aepetersMD]

Kudos to @SaeidMirzaiDOMS for leading this comprehensive SoTA review! Important time for both implementation and new strategies for exercise interventions in HFpEF. @robmentz @ParagGoyalMD @JasonFanning1 @agingup @AndreasGevaert @HFpEF .(https://t.co/rRJigbkzuK)

[Issam Motairek, MD @IMotairek]

🚨 Great work from our Cardio-Rheumatology Center: Over 22 years, CV mortality in IMID patients fell but women still faced ~50% higher risk. @farah_abdulhai @BadwanMD @RochellIssa7 @CalcagnoTess @SaeidMirzaiDOMS @HollandTamis @DrHebaMD @CleClinicHVTI @CCF_IMCHIEFS @CircAHA

[Annalisa Filtz @AnnalisaFiltz]

Refining cardiovascular risk assessment: The interplay of Lp(a) and waist-to-hip ratio

💫 Read the Editorial I had the honor to write w/ @DrMarthaGulati
https://t.co/XY9fUvkcQ8

🔗Article @PCVDJournal
https://t.co/HkStTC64nF

@DrMichaelShapir @khurramn1 @rblument1 @CardioMDPhD

[Voronoi Health Analytics Inc. @VoronoiHealth]

We would like to highlight work conducted by researchers from @ClevelandClinic @wakeforestmed & @cwru. They used DAFS to quantify multi-region adipose tissue depots and LS (liver-spleen) ratio in patients undergoing cardiac resynchronization therapy.

Voronoi Health Analytics supports world-renowned institutions and researchers in uncovering some of human health's most complex issues by quantifying multi-tissue and multi-organ data through AI.

Read about their work here:
https://t.co/Pkof4gkhYX

[Rishi Rikhi, MD🌱MS @RishiRikhiMD]

Check out our two reviews on Lp(a) as a causal risk factor for CVD and clinical trials for treating Lp(a)!
@SaeidMirzaiDOMS @DrMichaelShapir @DrNathanWong

https://t.co/goWzOEEJEc

https://t.co/myREw1gtLa

[Josh Longinow, D.O. @J_longinow]

Pleased to share our work highlighting the impact of body composition parameters in #CardiacAmyloid in the #EJHF!

Thankful to @WilsonTangMD for his mentorship, to my co-author @SaeidMirzaiDOMS, and for the efforts of all involved. Teamwork makes research fun. @ESC_Journals

[Jasmine Sethi @JasmineNephro]

❤️‍🩹 Diuresis in heart failure

https://t.co/Bt6fcbmOuu

[Richard Kazibwe, MD, MS, FACP @Kazibwe_md]

In this paper, we examined the hotly debated impact of statins on cognitive health. 🧠📊 The ongoing trials, PREVENTABLE & STAREE, may help clear some of the controversies. #Statins #Cognition #CVD_Prevention. https://t.co/OJe0y6nAU7

[The Heart @ZHeart11768530]

🔴How do we maximize diuresis in #ADHF ? #OpenAccess #2023Review

🔹https://t.co/gbCHoxu7Xe
#cardiotwiteros #medtwitter #meded #medical #CardioEd #CardioTwitter #cardiology #paramedic #ekg #medicine

[Hypertension @HyperAHA]

@SaeidMirzaiDO, @DrMichaelShapir, et al. show intensive BP control in older adults with #Sarcopenia & #Hypertension nearly halved CVD risk without increasing adverse event... @WilsonTangMD @totocarbone @msingletonep @paragchevli @RishiRikhiMD @kazibwe_MD

https://t.co/PMpGtPFvyW

[Ian Persits, DO, MS @ianpersits]

Awesome time at ACC in Atlanta. Special thanks to @WilsonTangMD @SaeidMirzaiDO @Kunaal_Sarnaik and Maximillian C. Volk (my curricular chief successor) #ACC2024 @Mud_Fud @CCF_IMCHIEFS @DrHebaMD @AndrewHigginsMD @PennyRampersad @RanLeeMD

[Farah Abdulhai @farah_abdulhai]

Got to present our findings on outcomes of heart failure in SLE patients under the guidance and mentorship of
@DrHebaMD @SaeidMirzaiDO @cardioreumatology with two very special guest appearances @CNKanaan @CCF_IMCHIEFS

[Saeid Mirzai @SaeidMirzaiDOMS]

@DrHebaMD @CCF_IMCHIEFS @ClevelandClinic It is a pleasure working with such a great team under your guidance to address the crucial topics of autoimmune disorders and cardiac disease, @DrHebaMD. Excited to share our findings in the upcoming manuscripts! @farah_abdulhai @cardiorheumatology

[JICE @JICE_EP]

🚨Latest #FreeRead in @JICE_EP

Preimplant Myopenia and Clinical Outcomes Among Patients with Heart Failure Undergoing Cardiac Resynchronization Therapy

📖🧐https://t.co/iMOfc4VvOn

by @SaeidMirzaiDO, Maximilian C. Volk, @ianpersits, Kunaal S. Sarnaik, @_LAM_PHD, Po-Hao Chen, John Rickard & @WilsonTangMD

#EPeeps